Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Calibration of UV-Visible Spectrophotometer – V 2.0

Posted on By

Analytical Method Development: SOP for Calibration of UV-Visible Spectrophotometer – V 2.0

Standard Operating Procedure for UV-Visible Spectrophotometer Calibration in Method Development


Department Analytical Method Development
SOP No. SOP/AMD/355/2025
Supersedes SOP/AMD/355/2022
Page No. Page 1 of 13
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2027

1. Purpose

This SOP describes the standard procedure for calibration of UV-Visible spectrophotometers to ensure accurate, precise, and reliable performance in analytical method development. It includes wavelength accuracy, photometric accuracy, stray light, resolution, and baseline flatness

checks.

2. Scope

This SOP applies to all UV-Visible spectrophotometers used in the Analytical Method Development department of pharmaceutical API and formulation units.

3. Responsibilities

  • Analytical Instrumentation Chemist: Performs calibration as per schedule and documents all results.
  • QA Officer: Reviews calibration data and ensures compliance to specification.
  • Head – AMD: Authorizes final calibration status and usage clearance.
See also  Analytical Method Development: SOP for Validation of BET Method - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for implementation, documentation, review, and verification of spectrophotometer calibration programs.

5. Procedure

5.1 General Calibration Requirements

  1. Calibrate monthly or after instrument maintenance, relocation, or repairs.
  2. Use certified reference materials (CRM) or traceable calibration standards.
  3. Environmental conditions (temperature, humidity) must comply with equipment specifications.

5.2 Wavelength Accuracy Check

  1. Use Holmium Perchlorate solution or Didymium filters.
  2. Scan the solution or filter in the 200–700 nm range.
  3. Confirm that peak positions match certified values within ±1 nm.

5.3 Photometric Accuracy

  1. Prepare potassium dichromate solution at concentrations of 60, 40, and 20 ppm.
  2. Measure absorbance at 235, 257, 313, and 350 nm.
  3. Compare observed absorbance with theoretical values (±0.01 AU acceptable deviation).

5.4 Stray Light Test

  1. Use 1.2% potassium chloride solution in a quartz cell.
  2. Scan the solution and ensure absorbance at 200 nm is ≥ 2.0 AU.
  3. This confirms negligible stray light interference at low wavelengths.
See also  Analytical Method Development: SOP for Qualification of Working Standards - V 2.0

5.5 Resolution Power Check

  1. Scan 0.02% toluene in hexane between 260–280 nm.
  2. Ensure ratio of absorbance at 269 nm to 266 nm is ≥ 1.5 (US FDA and USP requirement).

5.6 Baseline Flatness and Noise

  1. Run baseline scan using air or blank quartz cells from 200 to 800 nm.
  2. Ensure deviation is within ±0.01 AU and noise is below acceptable limit (usually ±0.002 AU).

5.7 Documentation and Labeling

  1. Record calibration results in the Calibration Logbook (Annexure-1).
  2. Label instrument with status tag (CALIBRATED/OUT OF CALIBRATION).
  3. Retain calibration reports for minimum 3 years or as per regulatory requirement.

6. Abbreviations

  • AU: Absorbance Unit
  • nm: Nanometers
  • CRM: Certified Reference Material
  • QA: Quality Assurance

7. Documents

  1. Annexure-1: UV-Visible Spectrophotometer Calibration Log
  2. Annexure-2: Monthly Calibration Schedule

8. References

  • USP <857> – Ultraviolet-Visible Spectroscopy
  • ICH Q2(R1) – Validation of Analytical Procedures
  • FDA Guidance for Analytical Procedures and Methods Validation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Saurabh Mehta Meena Nair Dr. Anil Dubey
Designation Instrument Chemist QA Reviewer Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: UV-Visible Spectrophotometer Calibration Log

Date Parameter Observed Value Specification Status
01/06/2025 Wavelength Accuracy ±0.7 nm ±1.0 nm Pass
01/06/2025 Photometric Accuracy 0.001 AU deviation ±0.01 AU Pass
01/06/2025 Stray Light 2.3 AU ≥2.0 AU Pass

Annexure-2: Monthly Calibration Schedule

Lists all spectrophotometers by instrument ID with due dates and completion dates. Updated by instrumentation coordinator monthly.

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Included baseline flatness and stray light tests Annual Review Dr. Anil Dubey
01/06/2022 1.0 Initial release New SOP QA Head
See also  Analytical Method Development: SOP for Moisture Content Testing in Powder Formulations - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Elixir Department: SOP for Vendor Qualification for Raw Materials – V 2.0
Next Post: Analytical Method Development: SOP for Verification of Reference Standards and Working Standards – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version